GLP-1 receptor agonists and the future of Parkinson's

Renee Rouleau- M.S. Neuroscience and Bridges for Parkinson’s Medical Science Advisor

We’ve all heard of GLP-1 receptor agonists such as Ozempic, Wegovy, Exenatide and Monjouro because they’ve been advertised for weight loss! But these GLP-1 medications may have a few tricks up their sleeves beyond slimming waistlines, particularly when it comes to Parkinson’s (PD). Recent research indicates that these medications could have a role to play in supporting brain health and possibly in the future treatment of Parkinson’s disease (PD). However, before we go on, a quick word of caution: while this early research is exciting, long-term studies are limited, and much of this potential is still in the experimental stage. Still, science is intriguing and worth exploring — so let’s take a closer look.

READ MORE

---

Reach out to me anytime.
Yours, Coach B

Rock Steady Boxing Certified Coach
Certified Parkinson's Disease Fitness Specialist ISSA Certified Personal Trainer